CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: Olmesartan medoxomil
Accession: CHEBI:31932
browse the term
Synonyms: related_synonym: CS-866; CS866; Formula=C29H30N6O6; InChI=1S/C29H30N6O6/c1-5-8-23-30-25(29(3,4)38)24(27(36)39-16-22-17(2)40-28(37)41-22)35(23)15-18-11-13-19(14-12-18)20-9-6-7-10-21(20)26-31-33-34-32-26/h6-7,9-14,38H,5,8,15-16H2,1-4H3,(H,31,32,33,34); InChIKey=UQGKUQLKSCSZGY-UHFFFAOYSA-N; SMILES=CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O; olmetec
alt_id: CHEBI:93384
xref: CAS:144689-63-4; Drug_Central:1985; KEGG:D01204; LINCS:LSM-3767
xref_mesh: MESH:D000068557
G
Abcb11
ATP binding cassette subfamily B member 11
decreases activity
ISO
Olmesartan Medoxomil results in decreased activity of ABCB11 protein
CTD
PMID:23956101
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions
EXP
Olmesartan Medoxomil inhibits the reaction [Acetic Acid results in increased expression of BAX protein]
CTD
PMID:30594690
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
multiple interactions
EXP
Olmesartan Medoxomil inhibits the reaction [Acetic Acid results in decreased expression of BCL2 protein]
CTD
PMID:30594690
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Casp3
caspase 3
multiple interactions
EXP
Olmesartan Medoxomil inhibits the reaction [Acetic Acid results in increased expression of CASP3 protein]
CTD
PMID:30594690
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Cat
catalase
multiple interactions
EXP
Olmesartan Medoxomil inhibits the reaction [Acetic Acid results in decreased activity of CAT protein]
CTD
PMID:30594690
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Col1a1
collagen type I alpha 1 chain
decreases expression
EXP
Olmesartan Medoxomil results in decreased expression of COL1A1 mRNA
CTD
PMID:18501344
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
G
Crp
C-reactive protein
multiple interactions
EXP
Olmesartan Medoxomil inhibits the reaction [Acetic Acid results in increased expression of CRP protein]
CTD
PMID:30594690
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
G
Edn1
endothelin 1
decreases expression
EXP
Olmesartan Medoxomil results in decreased expression of EDN1 mRNA
CTD
PMID:16336959
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
G
Fasn
fatty acid synthase
decreases expression
EXP
Olmesartan Medoxomil results in decreased expression of FASN mRNA
CTD
PMID:18501344
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
G
Hmox1
heme oxygenase 1
multiple interactions
EXP
Olmesartan Medoxomil inhibits the reaction [Acetic Acid results in decreased expression of HMOX1 mRNA]
CTD
PMID:30594690
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Il10
interleukin 10
multiple interactions
EXP
Olmesartan Medoxomil inhibits the reaction [Acetic Acid results in decreased expression of IL10 protein]
CTD
PMID:30594690
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il15
interleukin 15
multiple interactions
ISO
Olmesartan Medoxomil results in increased expression of and results in increased secretion of IL15 protein
CTD
PMID:26423313
NCBI chr19:25,640,025...25,706,818
Ensembl chr19:25,640,251...25,706,820
G
Il1b
interleukin 1 beta
multiple interactions
EXP
Olmesartan Medoxomil inhibits the reaction [Acetic Acid results in increased expression of IL1B protein]
CTD
PMID:30594690
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
multiple interactions
EXP
Olmesartan Medoxomil inhibits the reaction [Acetic Acid results in increased expression of IL6 protein]
CTD
PMID:30594690
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Mpo
myeloperoxidase
multiple interactions
EXP
Olmesartan Medoxomil inhibits the reaction [Acetic Acid results in increased activity of MPO protein]; Olmesartan Medoxomil inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein]
CTD
PMID:23665423 PMID:30594690
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
G
Nfe2l2
NFE2 like bZIP transcription factor 2
multiple interactions
EXP
Olmesartan Medoxomil inhibits the reaction [Acetic Acid results in decreased expression of NFE2L2 mRNA]
CTD
PMID:30594690
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nfkbia
NFKB inhibitor alpha
multiple interactions
EXP
Olmesartan Medoxomil inhibits the reaction [Acetic Acid results in decreased expression of NFKBIA protein]; Olmesartan Medoxomil inhibits the reaction [Acetic Acid results in increased expression of NFKBIA mRNA]
CTD
PMID:30594690
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Nppb
natriuretic peptide B
decreases expression
EXP
Olmesartan Medoxomil results in decreased expression of NPPB mRNA
CTD
PMID:16336959
NCBI chr 5:158,416,813...158,418,175
Ensembl chr 5:158,416,866...158,418,168
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
EXP
Olmesartan Medoxomil inhibits the reaction [Acetic Acid results in increased expression of RELA mRNA]; Olmesartan Medoxomil inhibits the reaction [Acetic Acid results in increased expression of RELA protein]; Olmesartan Medoxomil inhibits the reaction [Acetic Acid results in increased phosphorylation of RELA protein]
CTD
PMID:30594690
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Serpine1
serpin family E member 1
decreases expression
EXP
Olmesartan Medoxomil results in decreased expression of SERPINE1 mRNA
CTD
PMID:18501344
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Srebf1
sterol regulatory element binding transcription factor 1
decreases expression
EXP
Olmesartan Medoxomil results in decreased expression of SREBF1 mRNA
CTD
PMID:18501344
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
G
Tgfb1
transforming growth factor, beta 1
decreases expression multiple interactions
EXP
Olmesartan Medoxomil results in decreased expression of TGFB1 mRNA Olmesartan Medoxomil inhibits the reaction [Acetic Acid results in increased expression of TGFB1 protein]
CTD
PMID:16336959 PMID:18501344 PMID:30594690
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tjp1
tight junction protein 1
affects localization
ISO
Olmesartan Medoxomil affects the localization of TJP1 protein
CTD
PMID:26423313
NCBI chr 1:118,849,838...119,094,492
Ensembl chr 1:118,849,838...119,094,432
G
Tnf
tumor necrosis factor
multiple interactions decreases expression
EXP
Olmesartan Medoxomil inhibits the reaction [Acetic Acid results in increased expression of TNF protein]; Olmesartan Medoxomil inhibits the reaction [Amiodarone results in increased expression of TNF mRNA]; Olmesartan Medoxomil inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein] Olmesartan Medoxomil results in decreased expression of TNF protein
CTD
PMID:18501344 PMID:23665423 PMID:26781185 PMID:30594690
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all